Your browser doesn't support javascript.
loading
Detection of disease-specific signatures in B cell repertoires of lymphomas using machine learning.
Schmidt-Barbo, Paul; Kalweit, Gabriel; Naouar, Mehdi; Paschold, Lisa; Willscher, Edith; Schultheiß, Christoph; Märkl, Bruno; Dirnhofer, Stefan; Tzankov, Alexandar; Binder, Mascha; Kalweit, Maria.
Afiliação
  • Schmidt-Barbo P; Department of Biomedicine, Translational Immuno-Oncology, University Hospital Basel, Basel, Switzerland.
  • Kalweit G; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.
  • Naouar M; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.
  • Paschold L; Neurorobotics Lab, University of Freiburg, Freiburg, Germany.
  • Willscher E; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.
  • Schultheiß C; Neurorobotics Lab, University of Freiburg, Freiburg, Germany.
  • Märkl B; Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Dirnhofer S; Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Tzankov A; Department of Biomedicine, Translational Immuno-Oncology, University Hospital Basel, Basel, Switzerland.
  • Binder M; Pathology, University Hospital Augsburg, Augsburg, Germany.
  • Kalweit M; Pathology, University Hospital Basel, Basel, Switzerland.
PLoS Comput Biol ; 20(7): e1011570, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38954728
ABSTRACT
The classification of B cell lymphomas-mainly based on light microscopy evaluation by a pathologist-requires many years of training. Since the B cell receptor (BCR) of the lymphoma clonotype and the microenvironmental immune architecture are important features discriminating different lymphoma subsets, we asked whether BCR repertoire next-generation sequencing (NGS) of lymphoma-infiltrated tissues in conjunction with machine learning algorithms could have diagnostic utility in the subclassification of these cancers. We trained a random forest and a linear classifier via logistic regression based on patterns of clonal distribution, VDJ gene usage and physico-chemical properties of the top-n most frequently represented clonotypes in the BCR repertoires of 620 paradigmatic lymphoma samples-nodular lymphocyte predominant B cell lymphoma (NLPBL), diffuse large B cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL)-alongside with 291 control samples. With regard to DLBCL and CLL, the models demonstrated optimal performance when utilizing only the most prevalent clonotype for classification, while in NLPBL-that has a dominant background of non-malignant bystander cells-a broader array of clonotypes enhanced model accuracy. Surprisingly, the straightforward logistic regression model performed best in this seemingly complex classification problem, suggesting linear separability in our chosen dimensions. It achieved a weighted F1-score of 0.84 on a test cohort including 125 samples from all three lymphoma entities and 58 samples from healthy individuals. Together, we provide proof-of-concept that at least the 3 studied lymphoma entities can be differentiated from each other using BCR repertoire NGS on lymphoma-infiltrated tissues by a trained machine learning model.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Aprendizado de Máquina Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Aprendizado de Máquina Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article